UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8‑K


CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  April 27, 2017
 
Cognex Corporation
(Exact name of registrant as specified in charter)
 
Massachusetts 001-34218
04-2713778
(State or other jurisdiction (Commission
(IRS Employer
of incorporation) File Number) Identification No.)
 
One Vision Drive, Natick, Massachusetts
01760-2059
(Address of principal executive offices)
(Zip Code)
 
 
Registrant’s telephone number, including area code:  (508) 650-3000
 
N/A
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company        q
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
q


Item 5.07  Submission of Matters to a Vote of Security Holders

On April 27, 2017, Cognex Corporation (the “Company”) held its 2017 Annual Meeting of Shareholders (the “Meeting”).  As of the record date for the Meeting, there were 86,649,349 shares of common stock of the Company outstanding and entitled to vote.  The 79,695,273 shares represented at the Meeting were voted as follows:

1.
The election of Patrick A. Alias, Theodor Krantz and J. Bruce Robinson as Directors to serve for a term ending in 2020. Each nominee for director was elected by a vote of the shareholders as follows:
 
  For Against Abstained
Broker
Non-Votes
           
  Patrick A. Alias 67,854,572 3,592,882 941,175 7,306,644
  Theodor Krantz 70,479,697 962,748 946,184 7,306,644
  J. Bruce Robinson 70,438,312 1,007,384 942,933 7,306,644
 
2.
To cast a non-binding advisory vote to approve the compensation of the Company’s named executive officers as described in the Proxy Statement including the Compensation Discussion and Analysis, compensation tables and narrative discussion (“say-on-pay”).  The proposal was approved by a vote of the shareholders as follows:
 
 
For
69,092,632
 
  Against
2,301,761
 
 
Abstained
994,236
 
 
Broker Non-Votes
7,306,644
 
 
3.
To cast a non-binding advisory vote regarding the frequency of “say-on-pay” proposals.  The voting results on this proposal were as follows:

  Annual
64,056,015
 
  Biennial
221,222
 
  Triennial
7,143,355
 
  Abstained
968,037
 
  Broker Non-Votes
7,306,644
 
 
 
Based on these results, and consistent with the recommendation of the Board of Directors, the Company will continue to conduct an advisory vote on the compensation of the Company’s named executive officers on an annual basis until the next advisory vote on the frequency of such say-on-pay votes.

4.
To ratify the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for fiscal year 2017.  The proposal was approved by a vote of the shareholders as follows:
 
 
For
78,168,740
 
  Against
568,195
 
 
Abstained
958,338
 
 
Broker Non-Votes
0
 
 

 
5.
To consider and act upon a shareholder proposal regarding the composition of the initial list of candidates from which new director nominees are chosen, if properly presented at the meeting.  The proposal was approved by a vote of the shareholders as follows:

 
For
44,777,144
 
  Against
26,535,741
 
 
Abstained
1,075,744
 
 
Broker Non-Votes
7,306,644
 
 
No other matters were voted upon at the Meeting.
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
COGNEX CORPORATION
 
 
 
 
Date: May 2, 2017
 
By:
/s/ John J. Curran
 
 
Name:
John J. Curran
   
Title:
Senior Vice President of Finance
and Chief Financial Officer